Barclays share price edges up as £500m buyback ends and BoE rate call nears
4 February 2026
1 min read

Barclays share price edges up as £500m buyback ends and BoE rate call nears

London, Feb 4, 2026, 08:32 GMT — Regular session

  • Shares of Barclays edged up roughly 0.3% in early London trading. The bank is set to release its full-year results on Feb. 10.
  • The bank has wrapped up a share buyback totaling about £500 million, cancelling over 107 million shares in the process
  • Investors are focused on the Bank of England’s Feb. 5 rate decision, seeking hints about where borrowing costs might head next

Barclays shares (BARC.L) rose 0.34% to 503.3 pence by 0810 GMT on Wednesday. Traders are gearing up for the bank’s full-year results, due Feb. 10. 1

The stock stayed steady ahead of a packed week for UK rates following Barclays’ completion of a £500 million share buyback, which will reduce its share count. Buybacks occur when a company repurchases its own stock, usually to cut the number of shares outstanding and boost earnings per share.

Barclays confirmed on Monday that it wrapped up the buyback programme announced on Oct. 23, 2025. On Jan. 30, it purchased 1,932,579 shares for cancellation at a volume-weighted average price of 487.5669 pence. The total repurchased shares reached 107,319,865, costing roughly £500 million, according to the filing. 2

Barclays reported in a separate statement that as of Jan. 31, it had 13,815,647,298 ordinary shares with voting rights outstanding, and no shares were held in treasury. 3

Rate expectations remain subdued as the Bank of England’s Monetary Policy Committee prepares to release its latest decision on Thursday. The Bank Rate stands at 3.75%, per the central bank’s calendar. 4

According to Reuters on Tuesday, the market is pricing in the BoE to keep rates steady at 3.75% this Thursday. Lee Hardman, MUFG’s senior currency analyst, told Reuters, “Markets now think the Bank of England will wait until probably the May policy meeting before cutting rates further.” 5

Lenders watch rates closely since shifts can alter the spread between loan earnings and deposit costs — a crucial factor for net interest income. Keeping cuts gradual helps preserve that margin but can put pressure on borrowers.

Barclays’ update on Feb. 10 comes shortly after the BoE decision, offering a snapshot of how the bank is handling margins, costs, and credit quality amid the shifting rate cycle. Investors will also be watching closely to see how the investment bank fares after a rocky start to dealmaking this year.

Still, the buyback isn’t a sure thing for the stock. If the BoE hints at quicker rate cuts or the economy falters with rising bad loans, investors could put more pressure on earnings forecasts and capital buffers.

The BoE decision on Feb. 5 comes first, with Barclays’ full-year results due on Feb. 10. These are the key near-term events poised to shift expectations for Barclays’ share price.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus
Previous Story

Shell stock jumps after Brazil Orca stake sale, with Q4 results next in focus

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool
Next Story

GSK beats 2025 sales targets — but new CEO warns 2026 growth will cool

Go toTop